Bladder Cancer
Related Subjects:
| Urothelial Tumours
| Haematuria
| Acute Urinary Retention
| Anuria and Oliguria
| Bladder Cancer
|Penile Cancer
| Renal Cell Carcinoma
| Benign Prostatic Hyperplasia
๐ About
- ๐น Bladder cancer is common in older adults, particularly men (โ3:1 male:female ratio).
- ๐จ Red flag: Any haematuria (visible or non-visible) must be investigated urgently.
โ๏ธ Aetiology
- Most cases present as superficial tumours (nonโmuscle invasive bladder cancer, NMIBC).
- Risk of progression depends on tumour grade, size, and multiplicity.
๐ฌ Pathology
- ~90% are urothelial carcinomas (transitional cell).
- ~8% are squamous cell carcinomas (linked to chronic irritation e.g. schistosomiasis ๐).
- ~2% are adenocarcinomas.
โ ๏ธ Risk Factors
- ๐ฌ Smoking โ accounts for ~50% of cases.
- ๐ญ Occupational: aromatic amines (dyes, rubber, leather), benzidine, petroleum, paint, and metal industries.
- ๐ Therapy-related: Cyclophosphamide (โ x10 risk), pelvic radiotherapy, some Chinese herbal medicines.
- ๐ฆ Infective/irritative: Schistosomiasis (especially SCC type).
๐ฉบ Clinical Features
- ๐ Painless visible haematuria โ the classic hallmark.
- ๐งป Storage symptoms: frequency, urgency, dysuria.
- โก Pelvic pain or obstructive uropathy in advanced disease.
- ๐ชซ Systemic features: uraemia, weight loss in late stages.
๐ Differentials
- UTI with haematuria.
- Coagulopathy causing bleeding.
- Renal cell carcinoma or upper tract urothelial cancer.
๐งช Investigations
- ๐ฉธ Bloods: FBC, U&E, LFTs, ESR/CRP.
- ๐ง Urinalysis & urine cytology (may detect atypical cells, not definitive).
- ๐ Cystoscopy with biopsy โ gold standard.
- ๐ผ๏ธ Imaging: CT urogram (abdomen/pelvis), USS (screening), IVU (historical).
- ๐ฆด Bone scan if bone pain or โALP suggests metastases.
๐ Management
- ๐ฑ Superficial bladder cancer (NMIBC):
- Treated with TURBT (transurethral resection of bladder tumour, including detrusor sampling).
- ยฑ Intravesical therapy: chemotherapy (e.g., mitomycin C) or BCG immunotherapy.
- Requires regular cystoscopic surveillance.
- ๐ Cystectomy if high-risk or multiple recurrences.
- ๐งฑ Muscle-invasive bladder cancer (MIBC):
- Gold standard: Radical cystectomy (with ileal conduit or neobladder).
- Radiotherapy as an alternative (often in frailer patients).
- ๐ฏ Neoadjuvant cisplatin-based chemotherapy can improve survival.
- ๐ Metastatic bladder cancer:
- Palliative chemotherapy (cisplatin-based if renal function allows).
- Palliative radiotherapy for local control, pain, or haematuria.
๐ References